Merck Data at ASCO 2019 Showcase Multiple Innovative Molecules with Potential to Impact Unmet Needs in Cancer Care
DARMSTADT, Germany, May 15, 2019 /PRNewswire/ --
Not intended for UK- , Canada- or US-based media
ASCO Abstract #
Bintrafusp alfa (bifunctional fusion protein): TPS9114; Tepotinib (MET kinase inhibitor): 9005; Discovery: 2567; ERBITUX ® (cetuximab): 3580; BAVENCIO ® (avelumab): 9569; 101; 4552; 4072
- New biomarker analyses for BAVENCIO ®* (avelumab) in combination with axitinib in first-line renal cell carcinoma (RCC)
- Data presented across several modalities and mechanisms showcase the scientific innovation and diversity of the company's pipeline, which includes bintrafusp alfaâ€ˇ (M7824) and tepotinibâ€
Merck, a leading science and technology company, today announced that data across several modalities and mechanisms targeting difficult-to-treat cancers will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31â€“June 4, Chicago, IL, US. New data will be presented for BAVENCIO ®* (avelumab) and ERBITUX ® (cetuximab), including rational combinations with chemotherapy, radiation therapy and other targeted agents to try to identify new ways to improve patient outcomes. This includes an oral presentation of data defining biomarkers that differentiate therapy-specific outcomes in patients with advanced renal cell carcinoma (RCC), and who have been treated first-line with BAVENCIO ® (avelumab) in combination with axitinib. Abstracts also showcase the scientific innovation and diversity of Merck's pipeline, with results from a number of high-priority clinical development programs, including tepotinibâ€ , bintrafusp alfaâ€ˇ (M7824) and the company's comprehensive DNA Damage Response (DDR) portfolio.
"At this year's ASCO meeting we continue to demonstrate the breadth and depth of our oncology and immuno-oncology portfolio. We will present examples of the latest precision medicine and biomarker research and some of the most exciting mechanisms being investigated today, including tepotinib and our first-in-class bifunctional fusion protein immunotherapy, bintrafusp alfa," said Luciano Rossetti, Global Head of Research & Development for the Biopharma business of Merck. "Merck's oncology pipeline has significant promise in the near term through our late-stage priority programs, and our early pipeline includes several potentially groundbreaking modalities. We look forward to sharing the latest science with the global oncology community."
For BAVENCIO ® (avelumab), Merck will share data from five studies across tumor types including Merkel cell carcinoma, RCC, hepatocellular carcinoma and urothelial carcinoma. This includes an oral presentation of biomarker analyses of baseline tumor samples from the Phase III JAVELIN Renal 101 trial in previously untreated patients with advanced RCC. The trial indicated that PD-L1 expression (â‰Ą1% immune cells) was associated with the longest progression-free survival (PFS) in the avelumab plus axitinib arm and the shortest PFS in the sunitinib arm (HR, 0.63; 95% CI, 0.49, 0.81). An analysis of relevant gene expression signatures (GES) indicated that in the avelumab plus axitinib arm, PFS was enhanced in immune GESâ€“positive patients vs those in the negative group (HR, 0.63; 95% CI, 0.46, 0.86; 2-sided p=0.004), and vs those in an independent dataset (JAVELIN Renal 100; Choueiri, Lancet Oncol, 2018) (HR, 0.46; 95% CI, 0.20, 1.05; 2-sided p=0.064). The combination demonstrated a safety and tolerability profile consistent with the known safety profiles of each drug alone. The most common adverse reactions (â‰Ą20%) were diarrhea, fatigue, hypertension, musculoskeletal pain, nausea, mucositis, palmar-plantar erythrodysesthesia, dysphonia, decreased appetite, hypothyroidism, rash, hepatotoxicity, cough, dyspnea, abdominal pain, and headache. Serious adverse reactions occurred in 35% of patients receiving BAVENCIO ® (avelumab) in combination with axitinib. The incidence of major adverse cardiovascular events (MACE) was higher with BAVENCIO ® (avelumab) in combination with axitinib vs sunitinib.
ERBITUX ® (cetuximab) data from a retrospective analysis of overall survival by subsequent therapy in patients with RAS wild-type metastatic colorectal cancer from the Phase III EPIC study will be presented, to evaluate the effect of post-study therapies (with ERBITUX ®, without ERBITUX ®, or no subsequent therapy) on OS.
A number of the molecules to be featured were discovered in-house at Merck. This includes tepotinib, an oral MET inhibitor designed to inhibit the oncogenic MET receptor signaling caused by MET (gene) alterations, and bintrafusp alfa, a bifunctional fusion protein designed to simultaneously target two immuno-suppressive pathways. Merck's partnership with GSK to jointly develop and commercialize bintrafusp alfa, announced in February 2019, is part of the company's strategic approach to oncology R&D. Together, Merck and GSK aim to rapidly and efficiently progress this molecule, which represents a potential step change in the treatment of cancer.
For tepotinib, promising updated results from the ongoing Phase II VISION study in 85 patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations (identified by liquid biopsy [LBx] or tumor biopsy [TBx]) will be shared. Results show an overall response rate (ORR) of 51.4% for LBx patients (independent review committee [IRC]-assessed) or 63.9% (investigator-assessed). The ORR for TBx patients was 41.5% (IRC-assessed) or 58.5% (investigator-assessed). Median duration of response was 9.8 (IRC-assessed) or 17.1 months (investigator-assessed) for LBx patients and 12.4 (IRC-assessed) or 14.3 months (investigator-assessed) for TBx patients. Any grade treatment-related adverse events (TRAEs) reported by â‰Ą10% of 69 patients evaluable for safety were peripheral edema (47.8%), diarrhea (18.8%), nausea (15.9%) and asthenia (10.1%). No Grade 4 or 5 TRAEs were observed. TRAEs led to permanent discontinuation in two (2.9%) patients (one interstitial lung disease, one diarrhea and nausea). These data continue to mature, and an updated data cut from the VISION study will be given as an oral presentation at the ASCO meeting on Monday, June 3.
For bintrafusp alfa, a trial-in-progress poster will be shared on the open-label study of bintrafusp alfa vs pembrolizumab as a first-line treatment in patients with PD-L1-expressing advanced NSCLC.
Merck takes a personalized approach to R&D, and precision medicine has long been a priority. Abstracts being presented at ASCO also include biomarker research programs that aim to help identify the patients most likely to benefit from specific treatments so they can achieve the best possible medical outcomes.
*The combination of BAVENCIO and axitinib is approved for the first-line treatment of advanced RCC only in the United States. There is no guarantee that avelumab in combination with axitinib will be approved for RCC by any other health authority worldwide.
â€ Tepotinib is the recommended International Nonproprietary Name (INN) for the MET kinase inhibitor (MSC2156119J). Tepotinib is currently under clinical investigation and not approved for any use anywhere in the world.
â€ˇBintrafusp alfa is the proposed International Nonproprietary Name (INN) for the bifunctional immunotherapy M7824. Bintrafusp alfa is currently under clinical investigation and not approved for any use anywhere in the world.
Notes to Editors
Key Merck-supported abstracts slated for presentation are listed below. In addition, a number of investigator-sponsored studies have been accepted (not listed).
Date / Time
BAVENCIO ® (avelumab)
Biomarker analyses from
JAVELIN Renal 101:
avelumab + axitinib
(A+Ax) vs sunitinib (S)
in advanced renal cell
Sat, Jun 1, 8:00
AM â€“ 9:30 AM
(8:12 AM â€“ 8:24
AM lecture time)
model for survival of
patients with metastatic
receiving 3 different
Mon, Jun 3, 1:15
PM â€“ 4:15 PM
First-line avelumab +
axitinib in patients with
carcinoma: results from
a phase 1b trial (VEGF
Mon, Jun 3, 8:00
AM â€“ 11:00 AM
analysis of metastatic
Merkel cell carcinoma to
biomarkers of response
Mon, Jun 3, 1:15
PM â€“ 4:15 PM
study of M7824 vs
pembrolizumab as first-
line (1L) treatment in
patients with PD-L1
non-small cell lung
Sun, Jun 2, 8:00
AM â€“ 11:00 AM
independence of multiple
predicting response to
Sat, Jun 1, 8:00
AM â€“ 11:00 AM
ERBITUX ® (cetuximab)
Retrospective Analysis of
Overall Survival (OS) by
Subsequent Therapy in
Patients With RAS-Wild-
type (wt) Metastatic
Cetuximab ± Irinotecan
Mon, Jun 3, 8:00
AM â€“ 11:00 AM
Phase II study of
NSCLC patients with
Mon, Jun 3, 8:00 AM â€“
11:00 AM (9:24
AM â€“ 9:36 AM
Tepotinib, discovered in-house at Merck, is an investigational oral MET inhibitor that is designed to inhibit the oncogenic MET receptor signaling caused by MET (gene) alterations, including both MET exon 14 skipping mutations and MET amplifications, or MET protein overexpression. It has been designed to have a highly selective mechanism of action, with the potential to improve outcomes in aggressive tumors that have a poor prognosis and harbor these specific alterations.
Tepotinib is currently being investigated in NSCLC and Merck is actively assessing the potential of investigating tepotinib in combination with novel therapies and other tumor indications.
About Bintrafusp Alfa (M7824)
Bintrafusp alfa is an investigational bifunctional immunotherapy that is designed to combine a TGF-Î˛ trap with the anti-PD-L1 mechanism in one fusion protein. Bintrafusp alfa is designed to combine co-localized blocking of the two immuno-suppressive pathways â€“ targeting both pathways aims to control tumor growth by potentially restoring and enhancing anti-tumor responses. Bintrafusp alfa is currently in Phase I studies for solid tumors, as well as a randomized Phase II trial to investigate bintrafusp alfa compared with pembrolizumab as a first-line treatment in patients with PD-L1 expressing advanced NSCLC. The multicenter, randomized, open-label, controlled study is evaluating the safety and efficacy of bintrafusp alfa versus pembrolizumab as a monotherapy treatment.
To date, nearly 700 patients have been treated with bintrafusp alfa across more than 10 tumor types in Phase I studies. Encouraging data from the ongoing Phase I studies indicates bintrafusp alfa's potential safety and clinical anti-tumor activity across multiple types of difficult-to-treat cancers, including advanced NSCLC, human papillomavirus-associated cancers, biliary tract cancer and gastric cancer. In addition, in pre-clinical studies bintrafusp alfa demonstrated superior anti-tumor activity, compared with anti-PD-L1 alone or with anti-PD-L1 and TGF-Î˛ trap when co-administered. In total, eight high-priority immuno-oncology clinical development studies are ongoing or expected to commence in 2019, including studies in non-small cell lung and biliary tract cancers.
About BAVENCIO ® (avelumab)
BAVENCIO is a human anti-programmed death ligand-1 (PD-L1) antibody. BAVENCIO has been shown in preclinical models to engage both the adaptive and innate immune functions. By blocking the interaction of PD-L1 with PD-1 receptors, BAVENCIO has been shown to release the suppression of the T cell-mediated antitumor immune response in preclinical models.1-3 BAVENCIO has also been shown to induce NK cell-mediated direct tumor cell lysis via antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro.3-5 In November 2014, Merck and Pfizer announced a strategic alliance to co-develop and co-commercialize BAVENCIO.
The clinical development program for avelumab, known as JAVELIN, involves at least 30 clinical programs and about 10,000 patients evaluated across more than 15 different tumor types. These tumor types include RCC, gastric/gastro-esophageal junction cancer, head and neck cancer, Merkel cell carcinoma, non-small cell lung cancer, and urothelial carcinoma.
BAVENCIO approved Indications
In September 2017, the European Commission granted conditional marketing authorization for BAVENCIO as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC). BAVENCIO is currently approved for patients with MCC in more than 45 countries globally, with the majority of these approvals in a broad indication that is not limited to a specific line of treatment.
BAVENCIO ® (avelumab) in combination with axitinib is indicated in the US for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
In the US, the FDA granted accelerated approval for BAVENCIO for the treatment of (i) adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (mMCC) and (ii) patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. These indications are approved under accelerated approval based on tumor response rate and duration of response. Continued approval for these indications may be contingent upon verification and description of clinical benefit in confirmatory trials.
BAVENCIO ® Safety Profile from the EU Summary of Product Characteristics (SmPC)
The special warnings and precautions for use for BAVENCIO include infusion-related reactions and immune-related adverse reactions (such as pneumonitis, hepatitis, colitis, endocrinopathies, nephritis and renal dysfunction, and other adverse reactions).
The SmPC list of the most common adverse reactions in patients with solid tumors includes fatigue, nausea, diarrhea, decreased appetite, constipation, infusion-related reactions, and weight loss and vomiting.
Axitinib Important Safety Information from the US FDA Approved Label
In the study of advanced RCC after failure of one prior systemic therapy, the warnings and precautions for axitinib include hypertension, including hypertensive crisis, arterial and venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation and fistula, hypothyroidism, wound healing complications, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, hepatic impairment, and fetal harm during pregnancy.
Common adverse events (reported in at least 20% of patients) in patients receiving axitinib were diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, hand-foot syndrome, weight decreased, vomiting, asthenia, and constipation.
About ERBITUX ® (cetuximab)
Erbitux ® is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal antibody, the mode of action of Erbitux ® is distinct from standard non-selective chemotherapy treatments in that it specifically targets and binds to the EGFR. This binding inhibits the activation of the receptor and the subsequent signal-transduction pathway, which results in reducing both the invasion of normal tissues by tumor cells and the spread of tumors to new sites. It is also believed to inhibit the ability of tumor cells to repair the damage caused by chemotherapy and radiotherapy and to inhibit the formation of new blood vessels inside tumors, which appears to lead to an overall suppression of tumor growth. Based on in vitro evidence, Erbitux ® also targets cytotoxic immune effector cells towards EGFR-expressing tumor cells (antibody-dependent cell-mediated cytotoxicity [ADCC]).
Very commonly reported side effects with Erbitux ® include acne-like skin rash, mild to moderate infusion-related reactions and hypomagnesemia.
Erbitux ® has already obtained market authorization in 114 countries worldwide for the treatment of RAS wild-type metastatic colorectal cancer and for the treatment of squamous cell carcinoma of the head and neck. Merck licensed the right to market Erbitux ®, a registered trademark of ImClone LLC, outside the U.S. and Canada from ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company, in 1998.
- Dolan DE, et al. Cancer Control 2014;21:231â€“7.
- Dahan R, et al. Cancer Cell 2015;28:285â€“95.
- Boyerinas B, et al. Cancer Immunol Res 2015;3:1148â€“57.
- Kohrt HE, et al. Immunotherapy 2012;4:511â€“27.
- Hamilton G, et al. Expert Opin Biol Ther 2017;17:515â€“23.
All Merck press releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices â€“ Merck is everywhere. In 2018, Merck generated sales of â‚¬ 14.8 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
Phone: +1 978 821 5345
More News by PR Newswire India
Incubate, Measure and Amplify: The Circulate Initiative Launches Strategy to End Plastic Pollution and Build Thriving Circular Economies
Sunway Hotels & Resorts to Drive Higher MICE and Corporate Bookings In India Through GSA Appointment
2019 Taiwan-India Industrial Collaboration Summit held in Taipei on October 17
Jinergy to Impove Power Output of HJT Module to 530W
BlueVoyant Expands Operations to the Philippines and Signs Significant Partnership Deals
Earth Day Network Announces Countdown to the 50th Anniversary of Earth Day -- April 22, 2020
Tata Harper Introduces a Potent New Supernaturals 2.0 Rebrand
Over 50% Enterprises Believe 5G Will Help Customer Acquisition and Generate New Revenue Streams: Infosys Research
TissueCypherÂ® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences
Gogo and Airspan Partner for 5G Air-to-Ground Network Development and Roll-out
A Defining Moment: Maison Martell Presents the Daring New Martell XO
Royal Canadian Mint Silver Collector Coin Honours MĂ©tis Leader and Father of Manitoba Louis Riel
Senior Executives Predict a Recession within the Next 18 Months but Lack Preparedness, According to Russell Reynolds Associates Survey
OPPO PUBG MOBILE India Tour, a Smashing Success; Team Revenge eSports Wins INR 50,00,000
Hamad International Airport Expansion: Airport Capacity to Soar to More Than 60 Million Passengers Annually
Supermicro Servers Support Breakthrough NVIDIA EGX Platform Delivering AI Processing and Management from the Data Center to the Edge
Deltek Once Again Named A Best Place To Work in Asia
Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion
Weed Cellars Announces U.S. Launch
Indian Sub-continent's Most Comprehensive B2B Shows for Food, Health and Packaging
BioGX Receives CE-IVD Mark For Enhanced Flu Assay
Numonix Enhances Its Call Recording for MiVoice Connect to Support Encrypted Mitel 400 Series IP Phones
The UAE Calls for Innovative Ideas in Finding Solutions to Global Food Security Challenges
Philips India Launches CSR Campaign 'HarSaansMeinZindagi' to Promote Awareness on Childhood Pneumonia in India
Clicbrics Unveils Real Estate Festive Buying Trends
Volocopter Air Taxi Flies Over Singapore's Marina Bay
Business France Launches the Second Edition of its Major Annual Indo-French Business Forum: Ambition India 2020
Marg ERP's CMD Mr. Thakur Anup Singh Wins Prestigious Udyog Rattan Award
'Great Place to WorkÂ® India' Institute Crowns HashedIn as a Great Place to Work, Once Again in India
Xinhua Silk Road: China's Zoomlion rolls 120-tonne luffing tower cranes off production line
Future Generali India Life Insurance Company Limited Rolls Out 'Nayi Diwali Naya Rivaaj' Campaign
LG Innotek Publishes the 10th Sustainability Report
William O'Neil India Launches AlgoSmith for Retail Investors
Research Shows World at a Tipping Point to Meet Global Energy Goals by 2030 Without Urgent Investment
Mrs. Taruna Patel Initiates Seed Balls Campaign, 'Mix, Make and Throw to Grow' for the Protection of the Ecosystem
SHL Agrees To Acquire Aspiring Minds as Talent Strategy Becomes Critical for the Digital Era
Jelurida: Blockchain Anywhere With Ardor on Android
Wellington Drive Technologies third quarter update
GKN Powder Metallurgy Acquires FORECAST 3D, Expands Additive Manufacturing Capabilities to Include Plastics
RateGain Appoints Harmeet Singh as the New Chief Executive Officer
St. Mark's Hotel - A Boutique Luxury Hotel in the Heart of Bangalore - Uses Simplotel to Overhaul Their E-commerce
Alumni of JD Institute of Fashion Technology Soaring High at Bangalore Times Fashion Week 2019
A Spectrum of Royal Experiences at Phoenix Marketcity Kurla, This Diwali
Jetstay Brings Lowest Airfares to its Customers
Happiest Minds is the First Company Globally to Position Itself as "Born Digital . Born Agile"
ProtoPie Launches Major Update, Enabling Powerful, Collaborative Prototyping for Teams
Drug Delivery Devices Offering Enhanced Connectivity to Find Higher Uptake Among Hospitals
Sustainable Plasticizers and Novel Products Steer Global Plasticizers Market Expansion
YuppTV Join Forces With BSNL for a Triple Play Service Partnership
Dunzo Teams up With PUMA on Instant Deliveries for the 'Propah Lady' Campaign
New Research on Climate Change and the Brain, the Relationship Between Stroke and Dementia, Advances in Epilepsy and MS Among the Brain Health Initiatives Unveiled at 24th World Congress of Neurology
Cole Haan Announces Confidential Submission Of Draft Registration Statement For Proposed Initial Public Offering
Flip Your World View: Expo 2020 Dubai Aims to Turn Millions Into Global Changemakers as Event Marks One Year Countdown
Aireon Data Successfully Integrated With Atech SAGITARIO System
Pine Labs is Betting Big on the EMI Story: Announces a Strategic Alliance With SBI
Xinhua Silk Road: Moutai commits to enhancing cultural service, consumer experience
NASA Scientist Eric Lindstrom to Join Saildrone, Oversee Global Ocean Observing Fleet
Xinhua Silk Road: Moutai ranks among top ten liquor making companies in China
Hertz Asia Tops Regional Travel Awards
SkyFive Completes the Purchase of Nokia's Air-to-Ground Assets to Create World's First Specialist for Digital Broadband Networks for the Aviation Industry
Face Up To Rosacea: Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist
Sharda University Expands its Wings: Opens New Campus in Uzbekistan
Assam Company India Limited Aims to Quadruple its Production Capacity
2019 EBE China kicks off in Hangzhou
Michelin Starred Chef Vikas Khanna Shares the 'Recipe of Success' With Chitkara University Students
SAP partners with Microsoft for first-in-market cloud migration offerings
Xpress Money's Business Solution FLEX Strengthens, Powered by Collaborations With Banks, NBFIs and Online Remittance Players
Huawei Smart PV again leads PV Taiwan 2019
China's largest Gifts & Home Fair opened October 20
Xinhua Silk Road: 52 projects worth RMB128.3 bln inked on the Second Global Ningbo Community Development Partnership Conference
Women's World Banking hosts Making Finance Work for Women Summit in Singapore
Altium Extends Its Leadership in PCB Design With the Most Powerful Version of Altium Designer to Date
126th Canton Fair Witnesses Innovative Development in Home Appliance Products
Amplify Exchange Announces It Will Offer Commission-Free Trading
Goodbaby Launched New Products Designed by Dutch Illustrator Rick Berkelmans in Celebration of its 30th Anniversary
This Festive Season Philips Announces Exciting Offers Across TV and Audio Range
Focus on Exceptional Customer Service and Innovative Mobility Solutions Drives Enterprise Holdings to Another Record Year
ClĂ© de Peau BeautĂ© Unveils New La CrĂ¨me, a Recrafted Masterpiece
SC Johnson Launches Global Partnership to Fight Ocean Plastic and Poverty
IntelliStay Hotels Pvt Ltd (IHPL) Launch the iStay Hotels Brand With a 92 Room Flagship Property at Hi-Tech City, Hyderabad
The Bicester Village Shopping Collection Champions the Future of Fashion
The Economist set the Course for Sustainable Growth at the Annual India Summit 2019
STL Unveils Stellar Fibre, Industry's First Universal Fibre, at IMC 2019
Third Edition of Smart Asia 2019 Flagged off in Mumbai
Malaysia's Former Minister of Defence, Hishammuddin Hussein, Declares That His Country Deserves Better
Top Global Athletes and Sports Personalities Awarded at ANOC Awards 2019
IOF: A Fracture Every 3 Seconds Worldwide - That's Osteoporosis
Strategic Agreement Signed by Evergrande and Pininfarina for a New Range of Electric Vehicles
Chitkara University Student Invents a Single-use Plastic Substitute
MoU Signed Between Apex Professional University and National Institute of Unani Medicine
"MEDIA ALERT: Dutch Farm Group Are Not 'Unification Church' Members"
Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products
Xinhua Silk Road: Shaangu Group to break new ground with gold medal won at 2019 World Manufacturing Convention
Proudfoot and Strategia Worldwide Announce Partnership Integrated Risk Management and Operational Excellence Practices
Costa Rica Mystery: UK Reporter Still Missing After 10 Years
XKL Stands Behind Their Products
Digital Asset TDN Used to Acquire $25m of Graphite
Frost & Sullivan Reveals How to Shape Your Healthcare Strategy for 2020 in this $2 Trillion Market
Vimson Group and New Lab Partner to Explore New Possibilities in Mining
Speed Queen Launches a New Generation of Connected Washers and Dryers for Laundromats
Social Mobile Wins 2019 Innovation of the Year Award
JD Institute Receives Global Excellence in Design Education Award by Times
The Fullerton Hotel Sydney Debuts at No.1 Martin Place
Food Ingredients India & Health Ingredients (Fi India & Hi) and ProPak India: Indian sub-Continent's Most Comprehensive B2B Shows for Food, Health and Packaging by Informa Markets in India to be Held in Mumbai
Gratomic Signs Deal to Supply Graphite to Todaq
TikTok Democratizes eLearning With the Launch of the #EduTok Program
Pennar Industries Bags Orders Worth INR 304 Crore
FarEye Launches Flagship Solution to Help eCommerce Companies Scale Deliveries This Festive Season
Far East Hospitality Rethinks Luxury With the Launch of The Clan Hotel
ZTE wins 5G Excellence Award at the SDN/NFV World Congress
GELITA & Geltor Sign Letter of Intent to Commercialize First Animal-Free Biodesigned Collagen for Dietary Supplements, a Market with Huge Growth Potential
ZTE and China Unicom win Best Network Intelligence Award at Broadband Awards 2019
SECURA North Africa 2020 - The Fast-growing Safety & Security Event in Africa
EuroSchool Unveils Center for Excellence at its 3rd Campus in Pune, Announces Tie-up With Global Partners in Sports and Performing Arts
Xinhua Silk Road: SAIC Motor accelerates global expansion under BRI
Xinhua Silk Road: 2nd International Green Energy Development Conference held in east China's Yangzhong
Glenmark Pharmaceuticals Receives ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg
Lavelle Networks Recognized in Intel Network Builders Winners Circle for Acceleration of Network Transformation
/C O R R E C T I O N -- Brand Factory/
MetGen Earns Acclaim from Frost & Sullivan for its Unique, Customized Enzyme Technologies, METNINâ„˘ and ENZINEÂ®
AntWorks wins Frost & Sullivan Intelligent Automation Software Technology Innovation Award
Festive Season at VR Bengaluru, Whitefield Till November 3rd
SenRa and McWane Partner to Enable Smart Water Metering in India
Hexagon & MSC Software Showcases the Power of Autonomous Mobility and Immersive Experience at the New India Facility
Health Horizons Sheds Light on the Scientific Facts Behind the Benefits of Hemp
Pinterest Inspires Diwali Celebrations Around the World
Ambica Steels Limited Gets Certified as an Accredited Company to be a Credible Supplier to the Automotive Industry
Never Before Payment Offer at Rustomjee Urbania
Avishkar and A Advani Realty's 'The Platinum Towers' Contributes to the Commercial Boom in Kharadi
Apex Professional University (APU) to Host National Seminar on 'Human Rights: Prospects and Challenges'
Meet the future at Asia Agri-tech Expo & Forum 2019
NCRTC Rolls Out Wrench SmartProject as Their Common Data Environment in Record Time
Xinhua Silk Road: CEIS, Fitch Solutions jointly release report on opportunities in ASEAN under BRI
AWE2020: AWE Ten Years, Smartizing The Future
Fraudulent Transactions Cost APAC Businesses an Average of 3.4 Times the Amount of Lost Transaction Value: 2019 LexisNexis Risk Solutions True Cost of Fraud APAC Study
Avidity Science Acquires Edstrom Japan Ltd
Frost & Sullivan Lauds The Qt Company for Developing a Low-cost Unified UI/UX Software Platform for the Automotive Industry
Daniel Wellington Announces New Iconic Link Collection and Global Campaign Faces
IMG Announces 2019 Leave Your Mark Contest Winners
JCSI Young Creatives Award Winners Announced
Special Operations Command's Intelligence, Electronic Warfare, and Cyberspace Operations to Fuel DoD C4ISR 2024 Spend
WebPort Global & Mediterranean Diet Roundtable Sign Partnership, Grow Online Community of Experts in Mediterranean Food Industry
Havas Health & You Becomes First Agency to Launch Creative Analytics Practice
Abu Dhabi Announces the Establishment of the World's First Graduate Level AI University
Quectel 5G Modules Selected by 100+ Global OEMs for 5G Designs
American Society of Agricultural and Biological Engineers partners with Impelsys to upgrade its publications synergy using iPC Scholar
Impelsys announces the launch of 2.0 version of its flagship platform iPC Scholar at the Frankfurt Book Fair
Infosys Instep Recognized as the Best 'Overall Internship Program' in the World
13th Edition of Renewable Energy India 2019: Witnesses a Strong Growth of 20% in Support of Green Energy
Artprice by Art Market: Will the Paris FIAC Be Able to Live Up to the Success of Frieze London?
Royal Canadian Mint's tri-metal token wins International Association of Currency Affairs' 2019 Excellence in Currency Award for Best new coin product, feature or distribution innovation
Microland Appoints Anupam Pandey as Chief Information Officer
Bajaj Housing Finance Limited has Provided Rs. 50 Crore Subsidy and Counting Under PMAY
IBM Boards the Mayflower Autonomous Ship Project
Drugs Made From Cancer Tissues and HIV Virus Found to be Effective Against Cancer, Says Research at Tata Institute
OMNICOMM Launches Next-generation Adaptable Fuel-level Sensors With 99.5% Guaranteed Accuracy
YES BANK Celebrates Childhood Through its Initiative, 'Cherishing Childhood'
Indonesian Healthcare Superapp Alodokter Raises USD 33M
New Website artfairmag.com Slated to Become Benchmark Site for Information on Art Fairs
/C O R R E C T I O N -- SenRa/
Web of Science Group Relaunches Master Journal List of 21k Journals
126th Canton Fair Kicks Off, Establishing an Open Platform for All
360 Finance's LendingAdda Launches Diwali Offers
360 Finance's LendingAdda Launches Credit Cards - Reshaping the User Experience
Vu Televisions Emerge as Market Leaders in Large Size and 4K Category in India
A Holistic Approach to Food and Nutrition Security This World Food Day
APU Celebrates its 3rd Convocation
SenRa and Bosch Partner to Deploy LoRaWANÂ® Solutions in India
LifeNet Health brings first clinically proven allograft-based biologic wound therapy to India
The Smart Contract Security Alliance Announces Founding Council
Patrick Imbardelli Elected to YPO Board of Directors
World Intellectual Property Indicators: Filings for Patents, Trademarks, Industrial Designs Reach Record Heights in 2018
Saudi Joy Forum 19, A Success For The Region And World
AIC Named North American Distributor Of Organic Rice, Organic Brown Rice And Organic Pumpkin Seed Proteins
WISPA Members Vote Cambium Networks Manufacturer of the Year
IMI and GustoMSC Sign Jack-up Design License Agreement
New Report: Laundry Releases Trillions of Plastic Microfibers Into the Ocean
FOX Bet Strikes Multiyear Deal With Major League Baseball
OhmniLabs Showcases Latest Telerobotics Innovations At CEATEC 2019
Airspan - Breaking Down the Barriers to Entry With the New Mimosa Connectorized A5x Access Point
TMP Worldwide Acquires UK-Based Social Media Leader Carve
CleverTap Completes $35 Million Series C Funding to Drive Global Growth
Charles Manning, Founder and CEO, Kochava, joins Forbes Technology Council
10th Foundation Day Celebrations Start at Shoolini University
Tourcom LLC, Holding Company of Tourcom Blockchain, Signs Strategic Investment Agreement through Equity Acquisition of Travel Information Sharing Service 'Wishbeen'
WorkBoard Announces Deeper Jira Integration to Bring Team OKRs into Developers' Jira Experience
Cision Announces Exclusive Platinum Sponsorship For PRSA 2019 International Conference
Systech Expands Market-Leading Brand Protection Solution for Improved Supply Chain Visibility
Artificial intelligence is transforming health care across Asia, fuelled by innovative public-private sector R&D and a focus on domestic health-care burdens
Sirius Design Group Generates $1.2m Revenue in 4 Years Helping Clients With Digital Real Estate
Dynata Launches New Platform to Transform the Future of Insights and Marketing
S BLOCK Co-Hosts WBF 2019 Indonesia Technology Conference, Creates DAO Super Community
TUV Rheinland Enables LoRaWAN(R) Certification in India
Tukatech Releases TUKAcad for Subscription in Native Languages for 4.38 Billion People
IDFC FIRST Bank and Sodexo Partner to Introduce Digital Meal Benefit Solution for Corporate Employees
Whale Cloud Unveils 5G Operation Map at India Mobile Congress 2019
LyondellBasell Announces Construction of New Small-Scale Molecular Recycling Facility
Celemics Expedites Target Enrichment NGS Data Insights by Partnering With BlueBee on a Global Genomics Data Solution
ZTE launches industry-first 5G+VDSL2 hybrid home gateway
OYO's HR Team Saved 75% At-risk Employees Using inFeedo's Engagement bot, Amber
Ameyo Integrates With Freshworks to Simplify Customer Journey
Nuclear Days 2019 - French Nuclear Industry to Intensify its Operations in Indian Market
Happiest Minds Wins 2019 Red Herring Top 100 Asia Award
The Spielwarenmesse Reveals the Trends for 2020
Xinhua Silk Road: SAIC Motor gains momentum in India with 31,000 orders received by September
CreditVidya Wins the Prestigious 2019 Red Herring Top 100 Asia Award
GCW Global Customised Wealth Announces New Partner: Tim Babich
GTPL Hathway's Consolidated H1 FY20 PAT at â‚ą 580 Million, up by 102%
'Where Will Man Take Us?' by Atul Jalan has been Certified a National Bestseller by Penguin Random House India
Tejas Networks Launches World's Largest Disaggregated Packet-optical Switch at India Mobile Congress 2019
Building on Local Momentum: Malaysia's Greater Petaling Joins City Cancer Challenge
Shanghai International Money Fair - one of China's largest financial fairs will be held in December
Europe's Most Trusted Crypto And Precious Metal Companies Partner To Create Gold Token Secured By Bitcoin Network
RGE Commits US$200 Million to Next-Generation Textile Fibre Innovation and Technology
MedisantĂ© Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs
INSIDE INFORMATION: BW LPG Contemplated Sale of Shares
School House Crafts Multi-Sensory Journey of Discovery and Re-collection for La Mer Campaign Exhibition
Vevue Partners with CBX Exchange for Initial Auction Offering
Frost & Sullivan Recognizes Pepco Holdings and Carlsbad Municipal Water District with Excellence in Resourcefulness Awards at Itron Utility Week
His Holiness The Dalai Lama Awarded Honorary Doctorate by Chitkara University
Surplus Keslow Cinematography Gear Up For Auction
Libyan Investment Authority Loses Claim in the UK Court of Appeal - London
Artificial Intelligence for Risk Management Process by MovingNow
Maruti Suzuki Arena Devils Circuit Season 2019-20 Draws Over 6K Runners in Hyderabad
Quectel Achieves Industry's First 5G Data Call over 5G mmWave Module
Artprice by Artmarket: The Gagosian's Grand Projects for the Late Simon HantaĂŻ (1922-2008)
Ryan International Group of Schools Receive India's Most Respected Brand Award 2019
JD Institute Of Fashion Technology, South Announced its New Domain
VeChain Is Leading Co-sponsor of GDST Seafood Trackathons
The World's Largest Automakers, Along with MOBI, Announce a Joint Proof of Concept for the First Vehicle Identity on Blockchain
Indiannica Learning Announces the Launch of Indiannica Quiz League
Third Annual Convocation Ceremony Will be Celebrated in Apex Professional University
An Encounter of Two Icons: Tic TacÂ® Meets Coca-ColaÂ®
Birlasoft to Accelerate Invacare's Business Transformation Journey Signs US$ 240 mn, Multi-year Deal, to Provide Complete IT-as-a-Service (ITaaS)
Bali Zoo Celebrated Tumpek Kandang Ritual for all its Resident Faunas
Nitin Mantri Becomes ICCO President
DMCC Awarded 'Global Free Zone of the Year' for a Record Fifth Consecutive Year
Apex Professional University Signed MoU with Life Science Sector Skill Development Council